RC
PAHC icon

Rangeley Capital’s Phibro Animal Health PAHC Stock Holding History

Rangeley Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$628K Buy
+20,000
New +$844K 0.57% 48

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Rangeley Capital's PAHC Position: Q2 2026 in Review

Rangeley Capital opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 20,000 shares worth $628K. The stake represents 0.57% of the portfolio and ranks #48 among its holdings.

208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Rangeley Capital held 20,000 shares of Phibro Animal Health worth $628K as of Q2 2026.
  • Phibro Animal Health was a new Rangeley Capital position in Q2 2026.
  • Phibro Animal Health made up 0.57% of Rangeley Capital's portfolio in Q2 2026, its #48 holding.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.